An evaluative system for the response of antibacterial therapy: Based on the morphological change of Helicobacter pylori and mucosal inflammation

Pathology International

Volumn 49, Issue 4, 1999, Pages 332-337

  Wen, Min ^a,c   Zhang, Yali ^b   Yamada, Nobutaka ^a   Matsuhisa, Takeshi ^a   Matsukura, Norio ^a   Sugisaki, Yuichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b First Medical University   (China)

^c NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

Author keywords

Antibacterial therapy; Helicobacter pylori; Mucosal inflammation; Recrudescence; Remnant bacteria

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BREATH ANALYSIS; CELL INFILTRATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTRON MICROSCOPY; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSCOPY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; STOMACH MUCOSA;

ANTI-BACTERIAL AGENTS; BIOPSY; BREATH TESTS; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; TREATMENT OUTCOME; UREA;

EID: 0032896252     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00868.x     Document Type: Article

References (25)

1. 1 Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 11-14.
2. 2 Slomiany BL, Slomiany AA. Mechanism of Helicobacter pylori pathogenesis: Focus on mucus. J. Clin. Gastroenterol. 1992; 14 (Suppl. 1): 114-121.
3. 3 Kozol RA, Dekhne N. Helicobacter pylori and the pathogenesis of duodenal ulcer. J. Lab. Clin. Med. 1994; 124: 623-626.
4. 4 Suzuki H, Miura S, Suzuki M, Terada S, Nakamura M, Tsuchiya M. Gastric mucosal injury: Microcirculation and Helicobacter pylori. Keio J. Med. 1994; 43: 1-8.
5. 5 Korman MG. Helicobacter pylori eradication: Therapy other than with bismuth or proton-pump inhibitors. Scand. J. Gastroenterol. 1996; 220 (Suppl. 31): 413.
6. 6 Penston JG, Review AR. Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment. Pharmacol. Ther. 1996; 10: 469-486.
7. 7 Axon AT, Moayyedi P. Eradication of Helicobacter pylori: Omeprazole in combination with antibiotics. Scand. J. Gastroenterol. 1996; 215 (Suppl. 31): 82-89.
8. 8 Hunt RH. Helicobacter pylori eradication: A critical appraisal and current concerns. Scand. J. Gastroenterol. 1995; 210 (Suppl. 30): 73-76.
9. 9 Megraud F. Advantages and disadvantages of current diagnostic tests for the detection of Helicobacter pylori. Scand. J. Gastroenterol. 1996; 215 (Suppl. 31): 57-62.
10. 10 Megraud F. Diagnosis of Helicobacter pylori infection. Scand. J. Gastroenterol. 1996; 214 (Suppl. 31): 44-46.
11. 11 Cutler AF. Testing for Helicobacter pylori in clinical practice. Am. J. Med. 1996; 100(5A): 35-39.
12. 12 Bazzoli F, Zagari RM, Fossi S. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 1994; 6: 773-777.
13. 13 Syunji O, Haruaki S, Masalo A. Study on simplified staining method of Helicobacter pylori in gastric biopsy specimens. J. Med. Technol. 1996; 45: 717-721.
14. 13C-urea breath test for the detection of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 1991; 3: 905-911.
15. 15 Price AB. The Sydney System: Histological division. J. Gastroenterol. Hepatol. 1991; 6: 209-222.
16. 16 Stolte M, Eidt S. Helicobacter pylori and the evolution of gastritis. Scand. J. Gastroenterol. 1996; 214 (Suppl. 31): 13-16.
17. 17 Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992; 102: 720-727.
18. 18 Tytgat GNJ. Treatments that impact favorably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment. Pharm. Ther. 1994; 8: 359-368.
19. 19 Axon ATR. Eradication of Helicobacter pylori. Scand. J. Gastroenterol. 1996; 214 (Suppl. 31): 47-53.
20. 20 Bell GD, Powell KU, Burridge SM, Hassison G, Rameh B. Reinfection or recrudescence after apparently successful treatment of patients with duodenal ulcer disease. QJM 1993; 86: 375-382.
21. 21 Tytgat GNJ. Peptic ulcer and Helicobacter pylori: Eradication and relapse. Scand. J. Gastroenterol. 1995; 210 (Suppl. 30):70-72.
22. 22 Wyatt JI. Histopathology of gastroduodenal inflammation: The impact of Helicobacter pylori. Histopathology 1995; 26: 1-15.
23. 23 Megraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol. Clin. North. Am. 1993; 1: 73-88.
24. 24 Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment. Pharmacol. Ther. 1995; 9 (Suppl. 2): 33-39.
25. 25 National Institute of Health Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-69.